Excegran and white blood cell count decreased Patient Reports February 09, 2010

Excegran Side Effects Report #5900105-X
Excegran side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient, 70 years of age, was diagnosed with epilepsy , brain tumour operation and was treated with Excegran. After drug was administered, patient experienced the following side effects: jaundice , mucous membrane disorder, white blood cell count decreased. Excegran dosage: unknown. During the same period patient was treated with RISPERDAL, TEMODAL. Patient recovered.

Excegran Side Effects Report #4607712-5
Excegran side effect was reported by a Health Professional from on Mar 03, 2005. Female patient, 19 years of age, was diagnosed with epilepsy  and was treated with Excegran. After drug was administered, patient experienced the following side effects: erythema, platelet count decreased, rubella , viral infection , white blood cell count decreased. Excegran dosage: 100 MG, 2 IN 1 D, ORAL. During the same period patient was treated with DEPAKENE. Patient recovered.

Excegran Side Effects Report #6051062-X
Excegran side effect was reported by a Health Professional from JAPAN on Jan 16, 2009. Male patient, 69 years of age, was diagnosed with convulsion, anorexia and was treated with Excegran. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, white blood cell count decreased. Excegran dosage: unknown. During the same period patient was treated with GASMOTIN, DEPAS, ZYLORIC, PAXIL, CAMOSTATE, FOIPAN. Patient recovered.

Excegran Side Effects Report #5724474-9
Excegran side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 65 years of age, was diagnosed with convulsion, head injury and was treated with Excegran. After drug was administered, patient experienced the following side effects: erythema, granulocytopenia, metabolic acidosis, white blood cell count decreased. Excegran dosage: 200 MG, 2 IN 1 D, ORAL, 400 MG, 2 IN 1 D, ORAL. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, CIPROFLOXACIN, PERDIPINE LA, ENALAPRIL MALEATE, FAMOTIDINE. Patient recovered.